首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Quillaja saponin: A prospective emulsifier for the preparation of solid lipid nanoparticles
【24h】

Quillaja saponin: A prospective emulsifier for the preparation of solid lipid nanoparticles

机译:Quillaja皂苷:用于制备固体脂质纳米颗粒的预期乳化剂

获取原文
获取原文并翻译 | 示例
           

摘要

Quillaja saponin (QS) is a non-ionic amphiphilic surfactant of natural origin. In the present study, we evaluated its potential to form solid lipid nanoparticles (SLNs) in the presence of stearic acid (SA) as a lipid carrier and imatinib mesylate (IM) as a model drug. IM loaded solid lipid nanoparticles (IMSLNs) were prepared using the hot homogenisation method. Characterisation of IMSLNs revealed that they were quasi-spherical in shape, neutrally charged and 143.5-641.9 nm in size. Haemolysis, a toxicity issue of QS was not observed in SLNs. Comparative in vitro cytotoxicity analyses performed in human breast cancer cell line MCF7 revealed that IMSLNs were more toxic than IM. On the other hand, in vitro viability studies in the RAW264.7 cell line did not show any sign of toxicity by IMSLNs. Our results indicate that QS hold great potential in nano drug delivery as an emulsifier. (C) 2016 Elsevier B.V. All rights reserved.
机译:Quillaja皂苷(QS)是天然来源的非离子两亲性表面活性剂。在本研究中,我们评估了在存在硬脂酸(SA)作为脂质载体和甲磺酸伊马替尼(IM)作为模型药物的情况下形成固体脂质纳米颗粒(SLN)的潜力。使用热均质化方法制备了IM负载的固体脂质纳米颗粒(IMSLN)。 IMSLN的特征表明,它们呈准球形,带中性电荷,尺寸为143.5-641.9 nm。在SLN中未观察到溶血,QS的毒性问题。在人乳腺癌细胞MCF7中进行的体外细胞毒性比较分析表明,IMSLN比IM具有更高的毒性。另一方面,RAW264.7细胞系中的体外生存力研究未显示IMSLN有任何毒性迹象。我们的结果表明,QS作为乳化剂在纳米药物递送方面具有巨大潜力。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号